News for Getinge AB (GNGBF)

Order Intake Growth: 7.1% total growth, 2.9% organic growth.Net Sales Increase: 10.7% total increase, 6.2% organic growth.Adjusted Gross Margin: Improved by 0.

Apr 22, 2025 / 11:00AM GMTOperator Welcome to the Getinge Q1 report 2025. (Operator Instructions) Now I will hand the conference over to the speakers CEO, Matti

GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare - all while maintaining a strong focus on quality improvements and adapting to increasing market demands.

GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- 'In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions', says Mattias Perjos, CEO of Getinge.

Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ETCompany ParticipantsMattias Perjos - President & CEOAgneta Palmer -...

Getinge AB (publ) press release (GNGBF): Q4 Non-GAAP EPS of SEK 5.28. Revenue of SEK 11.07B (+11.7% Y/Y). Adjusted gross margin was 50.6%.

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.28%

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.19%

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.19%

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.19%

Sweden stocks higher at close of trade; OMX Stockholm 30 up 0.18%

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.45%

Sweden stocks higher at close of trade; OMX Stockholm 30 up 0.45%

The Intensive Care Unit Equipment Market Size sector reached a market value of USD 6.84 Billion in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 3.9%…

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.12%

Patient positioning systems industry is projected to witness a CAGR of 3.6% during the period 2024-2032. This growth can be attributed to technological...

The demand for automated cell culture is mainly driven by rising investments in cell-based research, advancements in cell culture technology, and an...

Medical products industry is projected to witness a CAGR of 5.7% during the period 2024-2032. This growth can be attributed to the increasing investments...

The global specialty lighting market size was valued at USD 7.77 billion in 2024 and is projected to reach from USD 8.32 billion in 2025 to USD 14.44...